Receptor Internalization

How Receptor Internalization Works

The Step-by-Step Process

Agonist Binds Receptor
        ↓
Receptor Activation
        ↓
GRK Phosphorylation
        ↓
Beta-Arrestin Recruitment
        ↓
Clathrin-Coated Pit Formation
        ↓
Membrane Invagination
        ↓
Vesicle Pinching (dynamin)
        ↓
Early Endosome
        ↓
Sorting Decision:
├── Recycling → Back to surface
├── Degradation → Lysosome
└── Signaling → Endosomal signaling

Key Components

Component	Function
Beta-arrestin	Scaffolds internalization machinery
Clathrin	Forms coated pits for endocytosis
Dynamin	GTPase that pinches off vesicles
Rab proteins	Direct endosomal trafficking
Sorting nexins	Determine recycling vs degradation

Types of Endocytosis

Clathrin-Dependent (Most Common for GPCRs)

• Arrestin recruits clathrin adaptor proteins
• Clathrin forms cage around membrane pit
• Dynamin severs vesicle from membrane
• Primary pathway for GLP-1, GH, insulin receptors

Clathrin-Independent

• Caveolae-mediated endocytosis
• Lipid raft-dependent pathways
• Some receptor types use these routes

Fate of Internalized Receptors

Three Possible Outcomes

Early Endosome
        ↓
    Sorting
   /   |   \
  ↓    ↓    ↓
Recycle  Signal  Degrade
  ↓       ↓        ↓
Back to  Continue  Lysosome
surface  from      (receptor
         endosome  destroyed)

Receptor-Specific Fates

Receptor	Primary Fate	Recovery Time
Beta-2 adrenergic	Fast recycling	~15 minutes
GLP-1 receptor	Slow recycling	1-4 hours
EGFR (with EGF)	Degradation	Hours (new synthesis)
Insulin receptor	Mixed	30-60 minutes

Internalization and Peptide Drug Action

GLP-1 Receptor Agonists

Semaglutide Binding
        ↓
GLP-1R Activation + Internalization
        ↓
Signaling Continues from Endosomes
        ↓
Slow Receptor Recycling
        ↓
Sustained Signaling
        ↓
Long Duration of Action

Why This Matters

Factor	Short-Acting	Long-Acting
Receptor fate	Fast recycling	Slow recycling + endosomal signaling
Dosing frequency	Multiple times daily	Weekly
Examples	Native GLP-1	Semaglutide

Endosomal Signaling

Signaling Continues After Internalization

Cell Surface Signaling
        ↓
Internalization
        ↓
Endosomal Signaling (different profile)
        ↓
May activate different pathways
        ↓
Distinct biological effects

Implications for Drug Design

• Some effects require surface signaling
• Some effects enhanced by endosomal signaling
• “Biased agonists” can favor one over other
• GLP-1R agonists benefit from endosomal signaling

Measuring Internalization

Laboratory Techniques

Method	What It Shows
Fluorescent ligand tracking	Real-time receptor movement
Surface biotinylation	Quantifies surface receptor loss
Immunofluorescence	Receptor localization in cells
Radioligand binding	Surface vs total receptor binding

Internalization Rate Determinants

Factors That Speed Internalization

• High agonist concentration
• High agonist efficacy (full vs partial)
• Efficient GRK phosphorylation
• High arrestin expression

Factors That Slow Internalization

• Partial agonists
• Antagonist presence
• GRK inhibition
• Arrestin mutations/knockdown

Therapeutic Implications

Drug Design Considerations

Goal	Strategy
Long action	Design for slow recycling
Avoid tolerance	Enable sufficient recycling
Sustained signaling	Promote endosomal signaling
Reduce side effects	Tissue-specific internalization

Example: GLP-1 Agonist Evolution

Native GLP-1
- Rapid internalization
- Fast degradation
- Minutes of action

        ↓ Engineering

Semaglutide
- Internalization with continued signaling
- Slow recycling
- Protected from degradation
- Days of action

Internalization and Side Effects

GI Side Effects of GLP-1 Agonists

GLP-1R Activation in GI Tract
        ↓
Delayed Gastric Emptying
        ↓
Nausea (especially at higher doses)
        ↓
Over Weeks: Receptor Internalization
        ↓
Some Receptors Downregulate
        ↓
GI Adaptation (less nausea)

This is why dose escalation is recommended, allowing GI adaptation.

Recycling vs Degradation Balance

Determining Factors

Favors Recycling	Favors Degradation
Short stimulation	Prolonged stimulation
Low agonist concentration	High concentration
Certain receptor types	Ubiquitination signals
Rab4/Rab11 activity	Rab7 activity

Clinical Relevance

• Fast recycling = shorter drug action, less tolerance
• Slow recycling = longer action, potential tolerance
• Degradation = receptor downregulation, need new synthesis

Frequently Asked Questions

Does internalization end receptor signaling?

Not necessarily. Many receptors continue to signal from endosomes after internalization. For some receptors like GLP-1R, endosomal signaling is an important component of their therapeutic effect. The location of signaling can affect which downstream pathways are activated.

Can internalization be used therapeutically?

Yes. Antibody-drug conjugates exploit internalization to deliver cytotoxic drugs into cancer cells. The antibody binds a surface receptor, gets internalized, and releases the drug inside the cell. Similar strategies are being explored for other therapeutic applications.

How does internalization differ from downregulation?

Internalization is the physical movement of receptors from surface to interior. Downregulation is the net reduction in total receptor number. Internalization can lead to downregulation if internalized receptors are degraded rather than recycled, but many internalized receptors do recycle back to the surface.